Uptrend Under Pressure 100
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 100/100 · 7 distribution days (SPY) Oct 26 Full briefing →
View
Simple research view

RMD · ResMed Inc.

$253.20 +0.13% Oct 26 close
Detected setup Golden Cross · Setup Score 55/100

Stand aside — setup invalidated

Setup score 55, but distribution days reach 5 or more — stand aside until the condition resets.

Ask about RMD

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$RMD

ResMed Inc.

ResMed Inc. is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $37B.

Health Technology Medical Specialties stock Stage 3 · Topping Base 2
$253.20 latest close
Market Structure
Trend structure: range
Latest event: structure_shift (bearish)
Support 218.03–218.65 · 4 touches · moderate
Support 245.21–245.97 · 3 touches · moderate
Resistance 262.17–264.09 · 3 touches · moderate
Resistance 259.99–261.00 · 3 touches · moderate
Support 241.66–242.40 · 3 touches · moderate
Verdict · setup score 55/100 · data Oct 26 close · latest session

Stand aside — setup invalidated

Setup score 55, but distribution days reach 5 or more — stand aside until the condition resets.

Recent price action · daily
$220$240$260AugSepOct$253

What would change this verdict

What needs to turn for this to become buyable — the top failing checks across the legend council:

  • Minervini 1.2 150-day MA > 200-day MA — MA150 $215.98 vs MA200 $225.09
  • Minervini 1.8 RS rank ≥ 70 (prefer ≥ 85) — RS rank 61
  • O'Neil C: Quarterly EPS acceleration ≥ 25% — +5.3% QoQ
  • O'Neil L: RS rank ≥ 80 (IBD leadership) — RS rank 61
  • Weinstein Stage 2 (Advancing phase) confirmed — Stage 3 (Topping)
  • Weinstein Volume expansion above average — Volume ratio 0.86x
Minority view — the council disagrees here
  • Minervini: avoid Trend-template read: fails 150-day MA > 200-day MA.
  • O'Neil: avoid CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
  • Weinstein: avoid Stage-analysis read: topping (Stage 3) is not an advancing Stage 2.
57 Neutral
Legend Score · rates the stock Neutral (57/100) — held back by eps growth

Our proprietary 0-100 rating — the answer to Wall Street's black-box scores. Five pillars, each computed from real scan data, each explained below in plain English.

  • Relative Strength (25%) 61
  • Trend Template (25%) 62
  • Institutional Footprint (20%) 73
  • EPS Growth (15%) 30
  • Quality (SMR-like) (15%) 44

RS rank 61: above-average strength. Trend template 5/8: mixed — some uptrend elements, some missing. Institutional score 73: mild accumulation. EPS up +0% — growing, but below the 25% leadership bar. Quality 44: weak fundamentals (sales growth 30, return on equity 41, leverage 100). Updated 2026-10-27.

Earnings

Pre-earnings setup

Next earnings Wednesday, October 28, 2026 Report time not confirmed by the source

Deterministic evidence

RMD+0.13%
Sector proxy · XLV+0.00%
Broad market · SPY+0.71%
Same completed session window ending 2026-10-26. RMD was +0.13 points vs XLV. -0.58 points vs SPY.
CatalystPending Stock reactionPositive Sector reactionWeak Opening surgePending Event riskEarnings-driven

Session internals Strong momentum

Rule: closed up, at or above the open, in the top third of the day's range. Judged on internals, not on the size of the move.

Vs prior close+0.13% From the open+0.68% Range position68% GapNo gap
QQQ confirmationConfirming (+1.11%) SMH confirmationConfirming (+2.74%)
Short-term conviction -1 points.
  • A sourced earnings report is still pending inside the risk window; ordinary technical conviction is reduced until it is out.
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $253.20 +0.1% Oct 26 close
52W High $277.67 8.8% below high
Wks Since High 35w
Base Depth 35.1%
RS Rank 22 percentile of scan
SMA 50 $230.11
Avg Vol 1,250,046
Rel Vol (Oct 26) 0.86× 2.38× on up days
More stats
52W Low $180.26
Tight Wks 1
Base B2
SMA 200 $225.09
RS Line vs High -16.8%
RS Line Slope +13.5% ▲
Group Rank #21/66
ADR% 2.3%
ATR(14) $5.78 (2.3%)
Vol Pace (live) N/A
A/D Days 13A / 12D
A/D Rating B
VDU Bars 0/10 d
Power Trend 9d
Earnings tomorrow
Position in 52-week range 75thpercentile of the 52-week range
$180.26low
$277.67high

RMD Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for RMD.

Create Free Account

Technical Analysis Report Card

$RMD · $253.20 · as of 2026-10-26 · multi-factor read
100
/ 100
Technicals 100/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▲ Uptrend
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$230.11 ↑
100-day$216.96 ↑
200-day$225.09 ↑
Golden Cross (fresh)

RSI (14)

Reading77.4 · Overbought

Overbought — buyers extended; watch for a pause or pullback.

MACD (12/26/9)

StateBullish
Histogram+2.267

Bullish — MACD above its signal line and above zero. Histogram contracting.

Bollinger Bands (20,2)

%B / Width90% · 20.0%

Near the upper band — buyers in control.

Volume · Buyer vs Seller

Up/Down vol2.38 · Accumulation
Rel volume0.86×
Pocket pivots · 10d1
5d vs 50d vol95%
Heavy vol up / down0 / 1

Accumulation — volume is concentrated on up days; buyers dominate. Recent volume is easing versus its baseline.

  • Pocket pivot 7 sessions ago — up-day volume beat every down day of the prior 10 sessions.
  • 1 heavy-volume down day vs 0 up in the last 20 sessions — supply is showing.

Support & Resistance

R · $277.6752-week high
Price · $253.20now
S · $216.92swing level
S · $202.00swing level
S · $198.62swing level

Fibonacci · Uptrend swing

23.6%$237.80
38.2%$226.80
50.0%$217.91
61.8%$209.03
78.6%$196.38

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for RMD — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishRSI overbought
Want this read in a legend's voice? Ask a Legend about RMD
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
How to read the numbers: the setup score (55/100, in the verdict band) rates this trade setup. Each legend's A–D grade rates the same setup against that legend's own checklist — so a high score next to a C grade is not a contradiction. The setup can be strong without fitting that legend's style. When the council disagrees, the verdict band breaks the tie.

Council consensus: 5 of 9 legends are Watching — building, not yet a confirmed buy.
Minervini Avoid C Trend-template read: fails 150-day MA > 200-day MA.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $253.20, MA150 $215.98, MA200 $225.09
1.4 50-day MA > 150-day MA AND 200-day MAMA50 $230.11, MA150 $215.98, MA200 $225.09
Failing evidence
1.2 150-day MA > 200-day MAMA150 $215.98 vs MA200 $225.09
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 61
7/12 checks
O'Neil Avoid D CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
Passing evidence
A: Annual earnings & revenue qualityRev +9.8% | ROE 24.8%
N: Near 52-week high or RS line new high8.8% below high | RS line new high: False
Failing evidence
C: Quarterly EPS acceleration ≥ 25%+5.3% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 61
3/8 checks
Weinstein Avoid C Stage-analysis read: topping (Stage 3) is not an advancing Stage 2.

partialRule check says AVOID (5/7 checks passed) — Stage-analysis read: topping (Stage 3) is not an advancing Stage 2.

Passing evidence
Price above 30-week MA (200-day proxy)Price $253.20 vs MA200 $225.09
30-week MA trending upwardFrom weekly scan context
Failing evidence
Stage 2 (Advancing phase) confirmedStage 3 (Topping)
Volume expansion above averageVolume ratio 0.86x
5/7 checks
dennis Watch C Turtle read: no breakout yet. Price is pressing the 20-day high. The system waits for the print; it never anticipates.
Passing evidence
No breakdown below the 20-day channel20-day low $218.03
Volatility-unit sizing (1N ≈ 1% of equity)1N = $5.76 (2.28% of price); the Turtles size 1 unit so a 1N move ≈ 1% of equity, making the 2N stop ≈ 2% equity risk
Failing evidence
S1: 20-day Donchian breakoutNot confirmed
S2: 55-day Donchian breakoutNot confirmed
5/7 checks
zanger Avoid C Zanger read: a hard gate is broken — either the pattern is not one of his six, or the entry is more than 5% past the breakout. He would not touch this.
Passing evidence
Not extended (≤5% above the breakout point)Measured as passing
Partial-profit plan: sell 20-30% at +15-20%Scale 20-30% at $291.18-$303.84; trail the rest
Failing evidence
Named Zanger pattern onlyGolden Cross is not one of Zanger's six
Breakout volume 1.5-2.0x averageData unavailable
4/6 checks
zweig Watch D Zweig read: part of his screen passes but not all: EPS growth above the market (≥15% QoQ); Insider buying; Price strength (RS ≥ 70) — wait for the full growth screen before treating this as a Zweig setup.
Passing evidence
Reasonable price for the growth (P/E ≤ 35)Trailing P/E 24.3x — no PEG or forward P/E stored
Breadth momentum: 10-day A/D ratio10-day A/D 1.17 (2025 adv / 1725 dec) — participation expanding
Failing evidence
EPS growth above the market (≥15% QoQ)+5.3% QoQ — Zweig wants growth above the S&P average
Insider buyingNo insider buying flagged
3/8 checks
Livermore Watch B Pivotal-point read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$253.20
Distance from 52-week high8.8% below high
Failing evidence
Relative strengthRS 61
Volume vs average0.86x
3/6 checks
Darvas Watch B Box-theory read: constructive evidence is present, but relative strength is unresolved.

partialConsolidating within the box (8.8% from 52W high) — patience until it approaches the prior high.

Passing evidence
Price$253.20
Distance from 52-week high8.8% below high
Failing evidence
Relative strengthRS 61
Volume vs average0.86x
3/6 checks
Wyckoff Watch B Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$253.20
Distance from 52-week high8.8% below high
Failing evidence
Relative strengthRS 61
Volume vs average0.86x
3/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
87RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +8 B
A: 19 D: 11 Net: +865 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 3/7 met
C 3/7 criteria
Separate score from the Minervini Trend Template (5/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
✗ EPS acceleration ≥25% QoQ +5%
✗ Revenue growth ≥20% YoY +10%
✓ Gross margin ≥30% 61%
✓ ROE ≥17% 25%
✗ RS rating ≥80 (leadership) 61
✗ Stage 2 uptrend (Weinstein) Stage 3
✓ Within 25% of 52W high -8.8%

Method Playbook

Trade it like Wyckoff EXACT LEVELS · PRO
Wyckoff B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the Spring/test, Sign of Strength, creek, or Last Point of Support boundary identified by the active structure.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a completed test or Sign of Strength/Last Point of Support confirmation with improving demand versus supply.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the Spring/test low or structural support whose failure would invalidate the accumulation read.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Raise protection beneath successive Last Points of Support or meaningful higher lows during markup; never loosen it.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on a failed Sign of Strength, support loss, or clear supply-dominant reversal such as an upthrust failure.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis

Golden Cross ⚠ Weinstein Stage 3 (topping) ⚠ Not actionable yet
55 setup score
RS Score 61
Trend template 5/8
CANSLIM 68.3* (B)
fast len: 50 slow len: 200 detector version: golden_cross/2026-09-27 cross bar ago: 10 cross price: 225.66 fast now: 230.11 slow now: 225.09 separation pct: 2.23 volume ratio: 0.894 depth pct: 5.84 geometry: {'cross_point': {'bar': 362, 'bars_ago': 10, 'price': 225.66, 'date': '2026-10-12'}, 'ring': {'bar': 362, 'bars_ago': 10, 'price': 225.66, 'date': '2026-10-12', 'color': 'gold', 'label': 'Golden Cross'}, 'fast_ma_line': {'label': '50-day SMA', 'start': {'bar': 313, 'bars_ago': 59, 'price': 199.3284, 'date': '2026-08-03'}, 'end': {'bar': 372, 'bars_ago': 0, 'price': 230.1092, 'date': '2026-10-26'}}, 'slow_ma_line': {'label': '200-day SMA', 'start': {'bar': 313, 'bars_ago': 59, 'price': 231.7372, 'date': '2026-08-03'}, 'end': {'bar': 372, 'bars_ago': 0, 'price': 225.0883, 'date': '2026-10-26'}}} confidence kind: heuristic_match findings: ['50-day SMA crossed above the 200-day SMA at ~$225.66 (2026-10-12, 10 bars ago)', 'Now: 50-day SMA $230.11 vs 200-day SMA $225.09; price $253.20 holding above the slow line', 'The fast average fell 5.8% from its pre-cross peak — this cross resolves that consolidation'] validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly trend template 5/8 confirmed
Why This Setup? D+W Confluence
Golden Cross · schematic

Golden Cross: the 50-day SMA just crossed above the 200-day SMA (~$225.66, 10 bars ago) — the classic long-term trend-turn signal. Price is holding above the slow line. Research/educational only, not a buy/sell recommendation. | Moderate trend (5/8) | Good RS (61) | High-confidence pattern (77%) | Accumulation (2.4× up/dn vol) | Power Trend | Readiness 51/100 (early) | CANSLIM 68.3 (B) | ⚠ Weinstein Stage 3 (topping); Not actionable yet

Wyckoff SOS ⚠ Volatility widening into breakout ⚠ Extended past buy zone ⚠ Not actionable yet
53 setup score
RS Score 61
Trend template 5/8
CANSLIM 65.9* (B)
range low: 191.25 range high: 224.417 range pct: 0.173 sos thrust: 0.065 sos vol ratio: 1.69 sos bars ago: 6 near lps: ✗ validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly: MA stabilizing or rising — accumulation context supported
Why This Setup? D+W Confluence
Wyckoff SOS · schematic

SOS: breakout above range_high=224.42, thrust=6.5%, vol=1.7x avg, lps=extended, 6 bars ago | Moderate trend (5/8) | Good RS (61) | High-confidence pattern (70%) | Accumulation (2.4× up/dn vol) | Power Trend | Readiness 39/100 (early) | CANSLIM 65.9 (B) | ⚠ Volatility widening into breakout; Extended past buy zone; Not actionable yet

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

2/7 universals met
  • A relative-strength leader — not met RS rank 22 — laggard
  • Clear of earnings — not met in 1 days — event risk
  • Not chasing (in range) — not met Not met — levels are a Pro detail
  • In a confirmed uptrend — partly met Stage 3 · Trend template 5/8 — not yet Stage 2
  • Volume confirms — partly met 0.9× average — light
  • Asymmetric reward — met Met — levels are a Pro detail
  • Risk is defined — met Met — levels are a Pro detail
Why these seven? → The Universal Edge

Minervini Trend Template

5/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $253.20 vs SMA150 $215.98 / SMA200 $225.09
SMA 150 above SMA 200 SMA150 $215.98 vs SMA200 $225.09
SMA 200 trending up Slope -1.24 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $230.11
Price above SMA 50 $253.20 vs SMA50 $230.11
30%+ above 52-week low +40.5% from $180.26
Within 25% of 52-week high -8.8% from $277.67
RS score above 70 RS 61

Fundamentals

52W Range
75%
Mkt Cap SEC
36.5B
EPS QoQ
+5%
Rev YoY
+10%
ROE
25%
Gross Margin
61%
D/E
0.11
EPS TTM
$10.43
P/E TTM
24.3x
Float
144M
Insider
No Buy

Company

Company profile
ResMed Inc.
RMD · NYSE · Health Technology · Medical Specialties
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B 68.3* CANSLIM * disqualified on C, M
C · Curr. EPS
63
A · Annual EPS
78
N · New Highs
100
S · Supply/Demand
80
L · Leader RS
61
I · Inst. Spons.
100
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
5/8
W. RS
66
W. Support
$180.26
W. Resist
$255.57
W. Patterns
Golden Cross
Weekly Structure

Scan History

20× streak
Oct 23: 55 (Golden Cross)Oct 26: 55 (Golden Cross)Oct 27: 55 (Golden Cross)55
Oct 27
Golden Cross
55
Oct 26
Golden Cross
55 0.0%
Oct 23
Golden Cross
55 +0.1%

Latest News

Headlines for RMD
Loading headlines…

Get the full picture on RMD

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial